反応式
C([O:4][CH2:5][C:6]([NH:25][C:26]([O:28][C:29]([CH3:32])([CH3:31])[CH3:30])=[O:27])([CH2:12][CH2:13][CH2:14][CH2:15][B:16]1[O:20][C:19]([CH3:22])([CH3:21])[C:18]([CH3:24])([CH3:23])[O:17]1)[C:7]([O:9][CH2:10][CH3:11])=[O:8])(=O)C.C(=O)([O-])[O-].[K+].[K+]>C(O)C>[C:29]([O:28][C:26]([NH:25][C:6]([CH2:5][OH:4])([CH2:12][CH2:13][CH2:14][CH2:15][B:16]1[O:17][C:18]([CH3:24])([CH3:23])[C:19]([CH3:22])([CH3:21])[O:20]1)[C:7]([O:9][CH2:10][CH3:11])=[O:8])=[O:27])([CH3:32])([CH3:30])[CH3:31]参加物
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
A solution of ethyl 2-(acetoxymethyl)-2-(tert-butoxycarbonylamino)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexanoate (12.0 g, 26.3 mmol) in ethanol (100 mL) was treated with solid potassium carbonate (3.62 g, 26.3 mmol) and stirred for 2 h. The solution was filtered and the filtrate was evaporated to dryness. The resulting residue was dissolved in ethyl acetate (150 mL) and washed successively with water (50 mL) and saturated aqueous sodium chloride (50 mL). Organic layer was concentrated and purified using a combiflash system (120 g column, eluting with 20-30% ethyl acetate in heptanes) to give ethyl 2-(tert-butoxycarbonylamino)-2-(hydroxymethyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexanoate (7.0 g, 78%). 1H NMR (CDCl3) δ 5.25 (bs, 1H), 4.00 (m, 2H), 3.91 (d, J=11.3 Hz, 1H), 3.60 (d, J=11.3 Hz, 1H), 1.53-1.46 (m, 1H), 1.23 (s, 9H), 1.21-1.15 (m, 1H), 1.06 (m, 7H), 1.03 (s, 12H), 0.90 (m, 1H), 0.54 (t, J=7.8 Hz, 2H). MS found for C20H38BNO7 m/z[438(M+Na)]
後処理
- filtrationThe solution was filtered
- customthe filtrate was evaporated to dryness
- dissolutionThe resulting residue was dissolved in ethyl acetate (150 mL)
- washwashed successively with water (50 mL) and saturated aqueous sodium chloride (50 mL)
- concentrationOrganic layer was concentrated
- custompurified
- washa combiflash system (120 g column, eluting with 20-30% ethyl acetate in heptanes)
出典と根拠
- ORDレコード
- ord-45e3041e8c664d99b721b686446a0fe3
- 出典データセット
- uspto-grants-2015_05
- 特許番号
- US09040703B2
関連ノート
読み込み中…